NTRB Nutriband Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NTRB

Price (delayed)

$3.58

Market cap

$43.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.58

Enterprise value

$39.19M

?
Relative Growth: Rel. Growth: 24
Relative Strength: Rel. Strength: 10
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 12

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal ...

Highlights
Nutriband's net income has increased by 36% from the previous quarter and by 21% YoY
The EPS has plunged by 161% YoY but it has grown by 16% from the previous quarter
Nutriband's quick ratio has increased by 34% YoY but it has decreased by 15% QoQ
Nutriband's gross profit has decreased by 26% QoQ and by 24% YoY
Nutriband's gross margin has decreased by 20% YoY and by 17% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://nutriband.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of NTRB

NTRB stock price

How has the Nutriband stock price performed over time
Intraday
1.99%
1 week
-1.78%
1 month
-3.24%
1 year
-56.23%
YTD
-21.15%
QTD
1.42%

Financial performance

How have Nutriband's revenue and profit performed over time
Revenue
$2.04M
Gross profit
$566,308
Operating income
-$8.32M
Net income
-$8.23M
Gross margin
27.8%
Net margin
-404.1%
Nutriband's net income has increased by 36% from the previous quarter and by 21% YoY
NTRB's operating income is up by 35% since the previous quarter and by 19% year-on-year
Nutriband's net margin has increased by 28% from the previous quarter and by 18% YoY
The operating margin is up by 28% QoQ and by 15% YoY

Price vs fundamentals

How does NTRB's price correlate with its fundamentals

Growth

What is Nutriband's growth rate over time

Valuation

What is Nutriband stock price valuation
P/E
N/A
P/B
6.53
P/S
20.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.24
The EPS has plunged by 161% YoY but it has grown by 16% from the previous quarter
The stock's price to book (P/B) is 42% less than its last 4 quarters average of 11.0 but 8% more than its 5-year quarterly average of 5.9
Nutriband's equity has decreased by 12% QoQ but it has increased by 3.9% YoY
The P/S is 37% less than the last 4 quarters average of 31.6 and 18% less than the 5-year quarterly average of 24.5
Nutriband's revenue has decreased by 11% from the previous quarter and by 4.8% YoY

Efficiency

How efficient is Nutriband business performance
The return on invested capital is up by 45% year-on-year and by 41% since the previous quarter
The ROS has grown by 28% from the previous quarter and by 18% YoY
Nutriband's return on equity has increased by 14% QoQ
The return on assets has grown by 13% since the previous quarter

Dividends

What is NTRB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRB.

Financial health

How did Nutriband financials performed over time
Nutriband's quick ratio has increased by 34% YoY but it has decreased by 15% QoQ
The current ratio has grown by 30% YoY but it has contracted by 16% from the previous quarter
Nutriband's debt is 96% less than its equity
Nutriband's debt to equity has increased by 33% from the previous quarter and by 33% YoY
Nutriband's debt has increased by 32% YoY but it has decreased by 4.9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.